LinckeT, SingerJ, KlugeR, SabriO, PaschkeR. 2009. Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies. Thyroid, 19:381–389.
2.
GarinE, DevillersA, Le CloirecJ, BernardAM, Lescouarc'hJ, HerryJY, ReubiJC, BourguetP. 1998. Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. Eur J Nucl Med, 25:687–694.
3.
JaapJ, Teunissen, KwekkeboomD, KrenningE. 2008. Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatosatin analogs. Trends Endocrinol Metab, 17:19–25.
4.
GörgesR, KahalyG, Mǘller-BrandJ, MäckeH, RoserHW, BockischA. 2001. Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer. Thyroid, 11:647–659.
